Covid-19 has accelerated the need for non-contact monitoring
New York, USA-based Nanowear is currently running an expanded coronavirus (Covid-19) remote diagnostic research project with Hackensack Meridian Health Systems, the largest hospital system in New Jersey, and the Maimonides Medical Center in Brooklyn, New York, USA.
The clinical trial collaboration is focused on the remote diagnostic monitoring of confirmed or suspected Covid-19 patients with Nanowear’s proprietary and patented fabric-based nanosensors, which detect physiological and biomarker changes indicative of clinical deterioration that may require further intervention from the hospital systems.
For the full story, see the October 2021 edition of Smart Textiles & Wearables.
Image: Nanowear